Responses
Regular and Young Investigator Award Abstracts
Clinical Trial In Progress
773 A phase I/II study to evaluate the safety, tolerability and preliminary efficacy of GLS-012 monotherapy and in combination with zimberelimab in patients with advanced melanoma (Triumph-01)
Compose a Response to This Article
Other responses
No responses have been published for this article.
